Company profile
AbCheck company profile
AbCheck provides an antibody discovery platform that discovers and optimizes human therapeutic antibodies. The company provides drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free agreements. It generates target-specific human antibody domains which can be used in distinct therapeutic formats. AbCheck was founded in 2009 and is a spin-out of Affimed’s technology discovery platform. It is a wholly owned subsidiary of Affimed GmbH, a biopharmaceutical company developing highly targeted cancer immunotherapies.
Business identity
- Contact email
- [email protected]
- Phone number
- +420 378 05 15 00
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Slavkov pod Hostýnem, Zlín, Czechia
- Postal code
- 301 00
- Country code
- CZ
- Continent
- Europe